4//SEC Filing
Delaney William E IV 4
Accession 0001209191-23-051910
CIK 0001426800other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:10 PM ET
Size
7.8 KB
Accession
0001209191-23-051910
Insider Transaction Report
Form 4
Delaney William E IV
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-10-02+10,000→ 152,744 total - Sale
Common Stock
2023-10-03$0.80/sh−1,891$1,504→ 150,853 total
Footnotes (3)
- [F1]Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024.
- [F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001812734
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:10 PM ET
- Size
- 7.8 KB